SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1210Dew, You belittled a fun little stock picking contest that's for charity andrkrw-1/6/2007
1209You’re a swell guy, Jim—I wish I could be like you. Why don’t all you wonderful DewDiligence_on_SI-1/6/2007
1208I received warm letters from the charities Tuck and Rick had chosen the prior twrkrw-1/6/2007
1207<i>How come you never enter the charity contest?</i> Model portfoliDewDiligence_on_SI-1/6/2007
1206Hey Dew, How come you never enter the charity contest? Wkeokalani'nui-1/6/2007
1205Mistake. EOM.keokalani'nui-1/6/2007
1204Hi Max, how are you doing? Increase (not large surge) in total plasma VEGF leveMiljenko Zuanic-1/5/2007
1203You're just purposely being obtuse. I said it was an intriguing program to frkrw-1/5/2007
1202Here’s what you said about GENR in 2005: investorshub.com <i> “<b>DDewDiligence_on_SI-1/5/2007
1201>>Evizon out, VEGF Trap is the only competitor to Lucentis now.<< Ntuck-1/5/2007
1200<i>patients elevation of VEGF in serum ranging from 1-10 fold above baseliBiomaven-1/5/2007
1199The patient VEGF serum level data from all the PI dosage showed patients elevatisilversurfer2007-1/5/2007
1198Peter, It appears that increases in VEGF levels had been observed in human triaPseudo Biologist-1/5/2007
1197Evizon out, VEGF Trap is the only competitor to Lucentis now.silversurfer2007-1/5/2007
1196I'll bet you another blue ginger lunch you won't find a bullish post frorkrw-1/5/2007
1195Miljenko was indeed a very early doubter of Squalamine/Evizon. That was the onlyDewDiligence_on_SI-1/5/2007
1194That’s revisionist history like I’ve never seen before from you. I can dig out yDewDiligence_on_SI-1/5/2007
1193<i>Miljenko is on the top of that list</i> Yuppers..I remember veryzeta1961-1/5/2007
1192You're funny. I told you ages ago the genr hype and your obnoxious poke pokerkrw-1/5/2007
1191<i>Why would anyone think of them as a competitor? Ever? Systemic genr no DewDiligence_on_SI-1/5/2007
1190Why would anyone think of them as a competitor? Ever? Systemic genr no more eye rkrw-1/5/2007
1189One fewer AMD competitor to think about.DewDiligence_on_SI-1/4/2007
1188Thanks PB. So that supports Silversurfer's point that the VEGF feedback loBiomaven-1/4/2007
1187Neither Avastin nor its mouse precursor, originally known as A4.6.1, appreciabPseudo Biologist-1/4/2007
1186Do you know if the pre-humanized predecessor to Avastin also bound only to humanBiomaven-1/4/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News